CC
RGEN icon

Centiva Capital’s Repligen RGEN Stock Holding History

Centiva Capital’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-21,261
Closed -$2.64M – 1726
2025
Q2 		$2.64M Buy
21,261
+3,814
+22% +$485K 0.04% 258
2025
Q1 		$2.22M Buy
+17,447
New +$2.69M 0.07% 154
2024
Q4 		– Sell
-9,430
Closed -$1.4M – 2275
2024
Q3 		$1.4M Sell
9,430
-654
-6% -$93.8K 0.03% 646
2024
Q2 		$1.27M Buy
10,084
+5,208
+107% +$816K 0.02% 655
2024
Q1 		$897K Buy
4,876
+3,242
+198% +$617K 0.02% 723
2023
Q4 		$294K Sell
1,634
-552
-25% -$85.9K 0.01% 1215
2023
Q3 		$348K Sell
2,186
-3,372
-61% -$551K 0.01% 1118
2023
Q2 		$786K Buy
+5,558
New +$891K 0.02% 656
2021
Q4 		– Sell
-883
Closed -$255K – 1489
2021
Q3 		$255K Sell
883
-6,014
-87% -$1.54M 0.02% 835
2021
Q2 		$1.38M Buy
6,897
+4,072
+144% +$790K 0.03% 443
2021
Q1 		$549K Buy
+2,825
New +$579K 0.02% 525

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Centiva Capital's RGEN Position: Q3 2025 in Review

Centiva Capital sold out of Repligen (RGEN) in Q3 2025, closing a stake of 21,261 shares — an estimated $2.64M sold.

Centiva Capital first reported a position in RGEN in Q1 2021 and held it in 11 quarters. The position peaked at $2.64M in Q2 2025. 453 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.

  • Centiva Capital reported no remaining Repligen position as of Q3 2025 after selling out during the quarter.
  • Centiva Capital sold 21,261 Repligen shares in Q3 2025, an estimated $2.64M.
  • Centiva Capital first reported a position in Repligen in Q1 2021 and held it in 11 quarters.
  • Centiva Capital's Repligen position peaked at $2.64M in Q2 2025.
  • 453 funds tracked by Wall St. Rank held Repligen as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.